mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression.

Abstract excerpt

Here, we showed that the acetylation-defective p53-4KR mice, lacking the ability of cell cycle arrest, senescence, apoptosis, and ferroptosis, were tumor prone but failed to develop early-onset tumors. By identifying a novel p53 acetylation site at lysine K136, we found that simultaneous mutations at all five acetylation sites (p53-5KR) diminished its remaining tumor suppression function. Moreover, the embryonic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acetylation
• Share to Carcinogenesis
• Share to Cell Cycle Checkpoints